Effects of different administration routes of esketamine on postoperative hyperalgesia in elderly patients undergoing laparoscopic gastrointestinal tumour surgery: a single-centre, prospective, randomised, double-blind, controlled trial
Abstract
<title>Abstract</title> <p> <bold>Background</bold> Opioid-induced hyperalgesia is a significant concern in elderly patients undergoing laparoscopic gastrointestinal tumour surgery. Esketamine, an N-methyl-D-aspartate receptor antagonist, may mitigate this risk; however, the optimal administration regimen in this population remains undefined. <bold>Methods</bold> To compare the effects of continuous infusion versus intermittent bolus administration of esketamine on postoperative hyperalgesia in elderly patients undergoing laparoscopic gastrointestinal tumour surgery.A single-centre, prospective, randomised, double-blind, placebo-controlled, parallel-group superiority trial with a 1:1:1 allocation ratio. Xing'an League People's Hospital, Inner Mongolia, China, from December 2023 to April 2025.Ninety-nine elderly patients (aged 60–76 years, ASA physical status II–III) scheduled for elective laparoscopic gastrointestinal tumour surgery. Patients were randomly allocated to three groups (n = 33 each): Group K1 received esketamine 0.25 mg·kg⁻¹ loading dose followed by continuous infusion at 0.2 mg·kg⁻¹·h⁻¹ until 30 min before the end of surgery; Group K2 received the same loading dose plus an additional 0.2 mg·kg⁻¹ bolus 30 min before wound closure; Group S (control) received sufentanil 0.2 µg·kg⁻¹ for induction plus normal saline infusion.The primary outcome was mechanical pain threshold (kgf) measured at 5 cm from the incision and at the medial forearm using an electronic Von Frey algometer preoperatively and at 2, 24, and 48 h postoperatively. Secondary outcomes included Visual Analogue Scale scores, perioperative opioid consumption, patient-controlled analgesia demands, and adverse events. <bold>Results</bold> Postoperative mechanical thresholds differed significantly among groups (p < 0.05). Group K1 showed lower Visual Analogue Scale scores, reduced intraoperative and 48-h postoperative opioid consumption, and fewer patient-controlled analgesia demands than Groups S and K2 (p < 0.05). Compared with Group S, Group K1 also had lower incidences of postoperative nausea and vomiting, breakthrough pain, and rescue analgesia (p < 0.05). No patient developed postoperative delirium. <bold>Conclusions</bold> Both continuous infusion and intermittent bolus administration of esketamine reduce postoperative hyperalgesia in elderly patients undergoing laparoscopic gastrointestinal tumour surgery; however, continuous infusion is superior in reducing opioid consumption and opioid-related adverse events. <bold>Trial registration</bold> The trial is registered with the China Clinical Trials Registry Registration Number: ChiCTR2400083196. </p>
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.